Deep brain stimulation (DBS) is a neuromodulatory treatment used in patients with drug‐
resistant epilepsy (DRE). The primary goal of this systematic review and meta‐analysis is to …

Epilepsy is a chronic disorder of the nervous system characterized by recurrent seizures.
Inflammation is one of the six major causes of epilepsy, and its role in the pathogenesis of …

Few studies have reported the clinical presentation, surgical treatment, outcomes and
influential factors for patients with epilepsy and Sturge-Weber syndrome. This large-scale …

Deep brain stimulation is a treatment option for patients with drug-resistant epilepsy. The
precise mechanism of neuromodulation in epilepsy is unknown, and biomarkers are needed …

Background: Deep brain stimulation (DBS) is an emerging and effective therapy for
Parkinson's disease (PD). However, little is known about its utilization, surgical populations …

Parkinson's disease (PD) is a neurodegenerative disease with a heavy burden on patients,
families, and society. Deep brain stimulation (DBS) can improve the symptoms of PD …

Objectives To evaluate the efficacy and safety of combined deep brain stimulation (DBS)
with capsulotomy for comorbid motor and psychiatric symptoms in patients with Tourette's …

Objective We present the findings related to seizure outcome during hippocampal deep
brain stimulation (Hip‐DBS) in patients with refractory temporal lobe epilepsy. Methods …

In the context of drug-resistant epilepsy, deep brain stimulation (DBS) has received FDA
approval. However, there have been reports of potential adverse effects, such as depression …

Epilepsy is one of the most common serious neurological disorders, affecting over 70 million
people worldwide. For the treatment of epilepsy, antiepileptic drugs (AEDs) and surgeries …